Bain Capital Fund XIV, L.P. (CIK 2016381) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-04-20). Recent activity: Buy KLRA (17.9M shares), Buy KLRA (8.4M shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-20 | Kailera Therapeutics, Inc. (KLRA) | Insider | Buy | 17.9M | $0 |
| 2026-04-20 | Kailera Therapeutics, Inc. (KLRA) | Insider | Buy | 8.4M | $134.4M |
Source: SEC Form 4 filings · as of 2026-04-20